R & D Partners

Ontherix, Inc., Sunnyvale, CA.
The Ontherix-Transporin Joint Development Program is focused on a late-preclinical stage drug, Nephrilin(TM), a first-in-class inhibitor of neuroinflammatory reactions to stress.

Molecular Medicine Research Institute, Sunnyvale, CA.
Transporin and MMRI have partnered to develop and sell the Transfexa(TM) line of research reagents through third-party vendors. These molecules allow rapid, targeted and efficient delivery of nucleic acids into cells, both in vivo and in vitro, without the use of lipid carriers. This technology is potentially transformative for the fields of RNAi and antisense technologies.

Goodwin Biotechnology, Inc., Plantation, FL.
This collaboration aims to sell novel solutions to clients whose antibody-based biopharmaceuticals are already utilizing the company's CMO services. The transporter technology may increase specificity of targeting in vivo, potentially differentiating the company's offering within a highly competitive space.

Shriners Burn Unit, Galveston, TX.    
This research collaboration has already generated novel insights into the mechanisms of action of Nephrilin(TM) in the treatment of severe burns. Some of this work is already published in peer-reviewed scientific journals.

University of Mississipi, Jackson, MS.
Our collaborator is looking at the potential use of our technology in the treatment of post-operative complications in heavy smokers.

Management Principal

Desmond Mascarenhas, Ph.D, Chief Executive
Mascarenhas owns three decades of experience in the technological innovation industries. He has established a successful track record as an entrepreneur, founding and operating ten corporate enterprises over the past eighteen years. Bioexpertise, Inc., a physician education company he founded in 2000 was recognized as an innovation leader in its field. Its clients included 12 of the 15 largest pharmaceutical companies. Mascarenhas has authored 30+ US patents and published dozens of peer-reviewed research papers. He holds a doctorate from Oxford University (which he attended as a Rhodes Scholar) and was a Post-doctorate Fellow at Stanford University.

© 2014-2015 Transporin, Inc